CHAPTER 1: INTRODUCTION
1.1. Report Description
1.2. Key Market Segments
1.3. Key Benefits
1.4. Research Methodology
1.4.1. Primary Research
1.4.2. Secondary Research
1.4.3. Analyst Tools and Models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO Perspective
CHAPTER 3: MARKET LANDSCAPE
3.1. Market Definition and Scope
3.2. Key Findings
3.2.1. Top Investment Pockets
3.2.2. Top Winning Strategies
3.3. Porter's Five Forces Analysis
3.3.1. Bargaining Power of Suppliers
3.3.2. Threat of New Entrants
3.3.3. Threat of Substitutes
3.3.4. Competitive Rivalry
3.3.5. Bargaining Power among Buyers
3.4. Market Dynamics
3.4.1. Drivers
3.4.2. Restraints
3.4.3. Opportunities
CHAPTER 4: IMMUNOASSAY MARKET, BY PRODUCT
4.1. Market Overview
4.1.1 Market Size and Forecast, By Product
4.2. Reagents And Kits
4.2.1. Key Market Trends, Growth Factors and Opportunities
4.2.2. Market Size and Forecast, By Region
4.2.3. Market Share Analysis, By Country
4.3. Analyzers
4.3.1. Key Market Trends, Growth Factors and Opportunities
4.3.2. Market Size and Forecast, By Region
4.3.3. Market Share Analysis, By Country
CHAPTER 5: IMMUNOASSAY MARKET, BY TECHNOLOGY
5.1. Market Overview
5.1.1 Market Size and Forecast, By Technology
5.2. ELISA
5.2.1. Key Market Trends, Growth Factors and Opportunities
5.2.2. Market Size and Forecast, By Region
5.2.3. Market Share Analysis, By Country
5.3. Chemiluminescence Immunoassay
5.3.1. Key Market Trends, Growth Factors and Opportunities
5.3.2. Market Size and Forecast, By Region
5.3.3. Market Share Analysis, By Country
5.4. Immunofluorescence Assay
5.4.1. Key Market Trends, Growth Factors and Opportunities
5.4.2. Market Size and Forecast, By Region
5.4.3. Market Share Analysis, By Country
5.5. Rapid Test
5.5.1. Key Market Trends, Growth Factors and Opportunities
5.5.2. Market Size and Forecast, By Region
5.5.3. Market Share Analysis, By Country
5.6. ELISpot
5.6.1. Key Market Trends, Growth Factors and Opportunities
5.6.2. Market Size and Forecast, By Region
5.6.3. Market Share Analysis, By Country
5.7. Western Blotting
5.7.1. Key Market Trends, Growth Factors and Opportunities
5.7.2. Market Size and Forecast, By Region
5.7.3. Market Share Analysis, By Country
5.8. Others
5.8.1. Key Market Trends, Growth Factors and Opportunities
5.8.2. Market Size and Forecast, By Region
5.8.3. Market Share Analysis, By Country
CHAPTER 6: IMMUNOASSAY MARKET, BY SPECIMEN
6.1. Market Overview
6.1.1 Market Size and Forecast, By Specimen
6.2. Infectious Diseases
6.2.1. Key Market Trends, Growth Factors and Opportunities
6.2.2. Market Size and Forecast, By Region
6.2.3. Market Share Analysis, By Country
6.3. Endocrinology
6.3.1. Key Market Trends, Growth Factors and Opportunities
6.3.2. Market Size and Forecast, By Region
6.3.3. Market Share Analysis, By Country
6.4. Oncology
6.4.1. Key Market Trends, Growth Factors and Opportunities
6.4.2. Market Size and Forecast, By Region
6.4.3. Market Share Analysis, By Country
6.5. Bone And Mineral Disorders
6.5.1. Key Market Trends, Growth Factors and Opportunities
6.5.2. Market Size and Forecast, By Region
6.5.3. Market Share Analysis, By Country
6.6. Cardiology
6.6.1. Key Market Trends, Growth Factors and Opportunities
6.6.2. Market Size and Forecast, By Region
6.6.3. Market Share Analysis, By Country
6.7. Blood Screening
6.7.1. Key Market Trends, Growth Factors and Opportunities
6.7.2. Market Size and Forecast, By Region
6.7.3. Market Share Analysis, By Country
6.8. Autoimmune Disorders
6.8.1. Key Market Trends, Growth Factors and Opportunities
6.8.2. Market Size and Forecast, By Region
6.8.3. Market Share Analysis, By Country
6.9. Allergy Diagnostics
6.9.1. Key Market Trends, Growth Factors and Opportunities
6.9.2. Market Size and Forecast, By Region
6.9.3. Market Share Analysis, By Country
6.10. Toxicology
6.10.1. Key Market Trends, Growth Factors and Opportunities
6.10.2. Market Size and Forecast, By Region
6.10.3. Market Share Analysis, By Country
6.11. Newborn Screening
6.11.1. Key Market Trends, Growth Factors and Opportunities
6.11.2. Market Size and Forecast, By Region
6.11.3. Market Share Analysis, By Country
6.12. Others
6.12.1. Key Market Trends, Growth Factors and Opportunities
6.12.2. Market Size and Forecast, By Region
6.12.3. Market Share Analysis, By Country
CHAPTER 7: IMMUNOASSAY MARKET, BY END USER
7.1. Market Overview
7.1.1 Market Size and Forecast, By End User
7.2. Hospitals And Clinics
7.2.1. Key Market Trends, Growth Factors and Opportunities
7.2.2. Market Size and Forecast, By Region
7.2.3. Market Share Analysis, By Country
7.3. Clinical Laboratories
7.3.1. Key Market Trends, Growth Factors and Opportunities
7.3.2. Market Size and Forecast, By Region
7.3.3. Market Share Analysis, By Country
7.4. Pharmaceutical And Biotechnology Companies
7.4.1. Key Market Trends, Growth Factors and Opportunities
7.4.2. Market Size and Forecast, By Region
7.4.3. Market Share Analysis, By Country
7.5. Blood Banks
7.5.1. Key Market Trends, Growth Factors and Opportunities
7.5.2. Market Size and Forecast, By Region
7.5.3. Market Share Analysis, By Country
7.6. Research And Academic Laboratories
7.6.1. Key Market Trends, Growth Factors and Opportunities
7.6.2. Market Size and Forecast, By Region
7.6.3. Market Share Analysis, By Country
7.7. Home Care Settings
7.7.1. Key Market Trends, Growth Factors and Opportunities
7.7.2. Market Size and Forecast, By Region
7.7.3. Market Share Analysis, By Country
CHAPTER 8: IMMUNOASSAY MARKET, BY REGION
8.1. Market Overview
8.1.1 Market Size and Forecast, By Region
8.2. North America
8.2.1. Key Market Trends and Opportunities
8.2.2. Market Size and Forecast, By Product
8.2.3. Market Size and Forecast, By Technology
8.2.4. Market Size and Forecast, By Specimen
8.2.5. Market Size and Forecast, By End User
8.2.6. Market Size and Forecast, By Country
8.2.7. U.S. Immunoassay Market
8.2.7.1. Market Size and Forecast, By Product
8.2.7.2. Market Size and Forecast, By Technology
8.2.7.3. Market Size and Forecast, By Specimen
8.2.7.4. Market Size and Forecast, By End User
8.2.8. Canada Immunoassay Market
8.2.8.1. Market Size and Forecast, By Product
8.2.8.2. Market Size and Forecast, By Technology
8.2.8.3. Market Size and Forecast, By Specimen
8.2.8.4. Market Size and Forecast, By End User
8.2.9. Mexico Immunoassay Market
8.2.9.1. Market Size and Forecast, By Product
8.2.9.2. Market Size and Forecast, By Technology
8.2.9.3. Market Size and Forecast, By Specimen
8.2.9.4. Market Size and Forecast, By End User
8.3. Europe
8.3.1. Key Market Trends and Opportunities
8.3.2. Market Size and Forecast, By Product
8.3.3. Market Size and Forecast, By Technology
8.3.4. Market Size and Forecast, By Specimen
8.3.5. Market Size and Forecast, By End User
8.3.6. Market Size and Forecast, By Country
8.3.7. France Immunoassay Market
8.3.7.1. Market Size and Forecast, By Product
8.3.7.2. Market Size and Forecast, By Technology
8.3.7.3. Market Size and Forecast, By Specimen
8.3.7.4. Market Size and Forecast, By End User
8.3.8. Germany Immunoassay Market
8.3.8.1. Market Size and Forecast, By Product
8.3.8.2. Market Size and Forecast, By Technology
8.3.8.3. Market Size and Forecast, By Specimen
8.3.8.4. Market Size and Forecast, By End User
8.3.9. Italy Immunoassay Market
8.3.9.1. Market Size and Forecast, By Product
8.3.9.2. Market Size and Forecast, By Technology
8.3.9.3. Market Size and Forecast, By Specimen
8.3.9.4. Market Size and Forecast, By End User
8.3.10. Spain Immunoassay Market
8.3.10.1. Market Size and Forecast, By Product
8.3.10.2. Market Size and Forecast, By Technology
8.3.10.3. Market Size and Forecast, By Specimen
8.3.10.4. Market Size and Forecast, By End User
8.3.11. UK Immunoassay Market
8.3.11.1. Market Size and Forecast, By Product
8.3.11.2. Market Size and Forecast, By Technology
8.3.11.3. Market Size and Forecast, By Specimen
8.3.11.4. Market Size and Forecast, By End User
8.3.12. Rest of Europe Immunoassay Market
8.3.12.1. Market Size and Forecast, By Product
8.3.12.2. Market Size and Forecast, By Technology
8.3.12.3. Market Size and Forecast, By Specimen
8.3.12.4. Market Size and Forecast, By End User
8.4. Asia-Pacific
8.4.1. Key Market Trends and Opportunities
8.4.2. Market Size and Forecast, By Product
8.4.3. Market Size and Forecast, By Technology
8.4.4. Market Size and Forecast, By Specimen
8.4.5. Market Size and Forecast, By End User
8.4.6. Market Size and Forecast, By Country
8.4.7. China Immunoassay Market
8.4.7.1. Market Size and Forecast, By Product
8.4.7.2. Market Size and Forecast, By Technology
8.4.7.3. Market Size and Forecast, By Specimen
8.4.7.4. Market Size and Forecast, By End User
8.4.8. Japan Immunoassay Market
8.4.8.1. Market Size and Forecast, By Product
8.4.8.2. Market Size and Forecast, By Technology
8.4.8.3. Market Size and Forecast, By Specimen
8.4.8.4. Market Size and Forecast, By End User
8.4.9. India Immunoassay Market
8.4.9.1. Market Size and Forecast, By Product
8.4.9.2. Market Size and Forecast, By Technology
8.4.9.3. Market Size and Forecast, By Specimen
8.4.9.4. Market Size and Forecast, By End User
8.4.10. South Korea Immunoassay Market
8.4.10.1. Market Size and Forecast, By Product
8.4.10.2. Market Size and Forecast, By Technology
8.4.10.3. Market Size and Forecast, By Specimen
8.4.10.4. Market Size and Forecast, By End User
8.4.11. Australia Immunoassay Market
8.4.11.1. Market Size and Forecast, By Product
8.4.11.2. Market Size and Forecast, By Technology
8.4.11.3. Market Size and Forecast, By Specimen
8.4.11.4. Market Size and Forecast, By End User
8.4.12. Rest of Asia-Pacific Immunoassay Market
8.4.12.1. Market Size and Forecast, By Product
8.4.12.2. Market Size and Forecast, By Technology
8.4.12.3. Market Size and Forecast, By Specimen
8.4.12.4. Market Size and Forecast, By End User
8.5. LAMEA
8.5.1. Key Market Trends and Opportunities
8.5.2. Market Size and Forecast, By Product
8.5.3. Market Size and Forecast, By Technology
8.5.4. Market Size and Forecast, By Specimen
8.5.5. Market Size and Forecast, By End User
8.5.6. Market Size and Forecast, By Country
8.5.7. Brazil Immunoassay Market
8.5.7.1. Market Size and Forecast, By Product
8.5.7.2. Market Size and Forecast, By Technology
8.5.7.3. Market Size and Forecast, By Specimen
8.5.7.4. Market Size and Forecast, By End User
8.5.8. South Africa Immunoassay Market
8.5.8.1. Market Size and Forecast, By Product
8.5.8.2. Market Size and Forecast, By Technology
8.5.8.3. Market Size and Forecast, By Specimen
8.5.8.4. Market Size and Forecast, By End User
8.5.9. Saudi Arabia Immunoassay Market
8.5.9.1. Market Size and Forecast, By Product
8.5.9.2. Market Size and Forecast, By Technology
8.5.9.3. Market Size and Forecast, By Specimen
8.5.9.4. Market Size and Forecast, By End User
8.5.10. Rest of LAMEA Immunoassay Market
8.5.10.1. Market Size and Forecast, By Product
8.5.10.2. Market Size and Forecast, By Technology
8.5.10.3. Market Size and Forecast, By Specimen
8.5.10.4. Market Size and Forecast, By End User
CHAPTER 9: COMPETITIVE LANDSCAPE
9.1. Introduction
9.2. Top Winning Strategies
9.3. Product Mapping of Top 10 Player
9.4. Competitive Dashboard
9.5. Competitive Heatmap
9.6. Top Player Positioning, 2023
CHAPTER 10: COMPANY PROFILES
10.1. F. Hoffmann-La Roche Ltd.
10.1.1. Company Overview
10.1.2. Key Executives
10.1.3. Company Snapshot
10.1.4. Operating Business Segments
10.1.5. Product Portfolio
10.1.6. Business Performance
10.1.7. Key Strategic Moves and Developments
10.2. Danaher Corporation
10.2.1. Company Overview
10.2.2. Key Executives
10.2.3. Company Snapshot
10.2.4. Operating Business Segments
10.2.5. Product Portfolio
10.2.6. Business Performance
10.2.7. Key Strategic Moves and Developments
10.3. Abbott Laboratories
10.3.1. Company Overview
10.3.2. Key Executives
10.3.3. Company Snapshot
10.3.4. Operating Business Segments
10.3.5. Product Portfolio
10.3.6. Business Performance
10.3.7. Key Strategic Moves and Developments
10.4. Siemens Healthineers
10.4.1. Company Overview
10.4.2. Key Executives
10.4.3. Company Snapshot
10.4.4. Operating Business Segments
10.4.5. Product Portfolio
10.4.6. Business Performance
10.4.7. Key Strategic Moves and Developments
10.5. DiaSorin S.p.A.
10.5.1. Company Overview
10.5.2. Key Executives
10.5.3. Company Snapshot
10.5.4. Operating Business Segments
10.5.5. Product Portfolio
10.5.6. Business Performance
10.5.7. Key Strategic Moves and Developments
10.6. Sysmex Corporation
10.6.1. Company Overview
10.6.2. Key Executives
10.6.3. Company Snapshot
10.6.4. Operating Business Segments
10.6.5. Product Portfolio
10.6.6. Business Performance
10.6.7. Key Strategic Moves and Developments
10.7. BioMerieux SA
10.7.1. Company Overview
10.7.2. Key Executives
10.7.3. Company Snapshot
10.7.4. Operating Business Segments
10.7.5. Product Portfolio
10.7.6. Business Performance
10.7.7. Key Strategic Moves and Developments
10.8. Ortho Clinical Diagnostics
10.8.1. Company Overview
10.8.2. Key Executives
10.8.3. Company Snapshot
10.8.4. Operating Business Segments
10.8.5. Product Portfolio
10.8.6. Business Performance
10.8.7. Key Strategic Moves and Developments
10.9. Thermo Fisher Scientific, Inc.
10.9.1. Company Overview
10.9.2. Key Executives
10.9.3. Company Snapshot
10.9.4. Operating Business Segments
10.9.5. Product Portfolio
10.9.6. Business Performance
10.9.7. Key Strategic Moves and Developments
10.10. Becton, Dickinson And Company
10.10.1. Company Overview
10.10.2. Key Executives
10.10.3. Company Snapshot
10.10.4. Operating Business Segments
10.10.5. Product Portfolio
10.10.6. Business Performance
10.10.7. Key Strategic Moves and Developments
10.11. Merck KGaA
10.11.1. Company Overview
10.11.2. Key Executives
10.11.3. Company Snapshot
10.11.4. Operating Business Segments
10.11.5. Product Portfolio
10.11.6. Business Performance
10.11.7. Key Strategic Moves and Developments
LIST OF TABLES
Table 1. Global Immunoassay Market, by Product, 2024 - 2033 ($Billion)
Table 2. Immunoassay Market for Reagents and Kits, by Region, 2024 - 2033 ($Billion)
Table 3. Immunoassay Market for Analyzers, by Region, 2024 - 2033 ($Billion)
Table 4. Global Immunoassay Market, by Technology, 2024 - 2033 ($Billion)
Table 5. Immunoassay Market for Elisa, by Region, 2024 - 2033 ($Billion)
Table 6. Immunoassay Market for Chemiluminescence Immunoassay, by Region, 2024 - 2033 ($Billion)
Table 7. Immunoassay Market for Immunofluorescence Assay, by Region, 2024 - 2033 ($Billion)
Table 8. Immunoassay Market for Rapid Test, by Region, 2024 - 2033 ($Billion)
Table 9. Immunoassay Market for Elispot, by Region, 2024 - 2033 ($Billion)
Table 10. Immunoassay Market for Western Blotting, by Region, 2024 - 2033 ($Billion)
Table 11. Immunoassay Market for Others, by Region, 2024 - 2033 ($Billion)
Table 12. Global Immunoassay Market, by Specimen, 2024 - 2033 ($Billion)
Table 13. Immunoassay Market for Infectious Diseases, by Region, 2024 - 2033 ($Billion)
Table 14. Immunoassay Market for Endocrinology, by Region, 2024 - 2033 ($Billion)
Table 15. Immunoassay Market for Oncology, by Region, 2024 - 2033 ($Billion)
Table 16. Immunoassay Market for Bone and Mineral Disorders, by Region, 2024 - 2033 ($Billion)
Table 17. Immunoassay Market for Cardiology, by Region, 2024 - 2033 ($Billion)
Table 18. Immunoassay Market for Blood Screening, by Region, 2024 - 2033 ($Billion)
Table 19. Immunoassay Market for Autoimmune Disorders, by Region, 2024 - 2033 ($Billion)
Table 20. Immunoassay Market for Allergy Diagnostics, by Region, 2024 - 2033 ($Billion)
Table 21. Immunoassay Market for Toxicology, by Region, 2024 - 2033 ($Billion)
Table 22. Immunoassay Market for Newborn Screening, by Region, 2024 - 2033 ($Billion)
Table 23. Immunoassay Market for Others, by Region, 2024 - 2033 ($Billion)
Table 24. Global Immunoassay Market, by End-user, 2024 - 2033 ($Billion)
Table 25. Immunoassay Market for Hospitals and Clinics, by Region, 2024 - 2033 ($Billion)
Table 26. Immunoassay Market for Clinical Laboratories, by Region, 2024 - 2033 ($Billion)
Table 27. Immunoassay Market for Pharmaceutical and Biotechnology Companies, by Region, 2024 - 2033 ($Billion)
Table 28. Immunoassay Market for Blood Banks, by Region, 2024 - 2033 ($Billion)
Table 29. Immunoassay Market for Research and Academic Laboratories, by Region, 2024 - 2033 ($Billion)
Table 30. Immunoassay Market for Home Care Settings, by Region, 2024 - 2033 ($Billion)
Table 31. Immunoassay Market, by Region, 2024 - 2033 ($Billion)
Table 32. North America Immunoassay Market, by Country, 2024 - 2033 ($Billion)
Table 33. North America Immunoassay Market, by Product, 2024 - 2033 ($Billion)
Table 34. North America Immunoassay Market, by Technology, 2024 - 2033 ($Billion)
Table 35. North America Immunoassay Market, by Specimen, 2024 - 2033 ($Billion)
Table 36. North America Immunoassay Market, by End-user, 2024 - 2033 ($Billion)
Table 37. U.S. Immunoassay Market, by Product, 2024 - 2033 ($Billion)
Table 38. U.S. Immunoassay Market, by Technology, 2024 - 2033 ($Billion)
Table 39. U.S. Immunoassay Market, by Specimen, 2024 - 2033 ($Billion)
Table 40. U.S. Immunoassay Market, by End-user, 2024 - 2033 ($Billion)
Table 41. Canada Immunoassay Market, by Product, 2024 - 2033 ($Billion)
Table 42. Canada Immunoassay Market, by Technology, 2024 - 2033 ($Billion)
Table 43. Canada Immunoassay Market, by Specimen, 2024 - 2033 ($Billion)
Table 44. Canada Immunoassay Market, by End-user, 2024 - 2033 ($Billion)
Table 45. Mexico Immunoassay Market, by Product, 2024 - 2033 ($Billion)
Table 46. Mexico Immunoassay Market, by Technology, 2024 - 2033 ($Billion)
Table 47. Mexico Immunoassay Market, by Specimen, 2024 - 2033 ($Billion)
Table 48. Mexico Immunoassay Market, by End-user, 2024 - 2033 ($Billion)
Table 49. Europe Immunoassay Market, by Country, 2024 - 2033 ($Billion)
Table 50. Europe Immunoassay Market, by Product, 2024 - 2033 ($Billion)
Table 51. Europe Immunoassay Market, by Technology, 2024 - 2033 ($Billion)
Table 52. Europe Immunoassay Market, by Specimen, 2024 - 2033 ($Billion)
Table 53. Europe Immunoassay Market, by End-user, 2024 - 2033 ($Billion)
Table 54. France Immunoassay Market, by Product, 2024 - 2033 ($Billion)
Table 55. France Immunoassay Market, by Technology, 2024 - 2033 ($Billion)
Table 56. France Immunoassay Market, by Specimen, 2024 - 2033 ($Billion)
Table 57. France Immunoassay Market, by End-user, 2024 - 2033 ($Billion)
Table 58. Germany Immunoassay Market, by Product, 2024 - 2033 ($Billion)
Table 59. Germany Immunoassay Market, by Technology, 2024 - 2033 ($Billion)
Table 60. Germany Immunoassay Market, by Specimen, 2024 - 2033 ($Billion)
Table 61. Germany Immunoassay Market, by End-user, 2024 - 2033 ($Billion)
Table 62. Italy Immunoassay Market, by Product, 2024 - 2033 ($Billion)
Table 63. Italy Immunoassay Market, by Technology, 2024 - 2033 ($Billion)
Table 64. Italy Immunoassay Market, by Specimen, 2024 - 2033 ($Billion)
Table 65. Italy Immunoassay Market, by End-user, 2024 - 2033 ($Billion)
Table 66. Spain Immunoassay Market, by Product, 2024 - 2033 ($Billion)
Table 67. Spain Immunoassay Market, by Technology, 2024 - 2033 ($Billion)
Table 68. Spain Immunoassay Market, by Specimen, 2024 - 2033 ($Billion)
Table 69. Spain Immunoassay Market, by End-user, 2024 - 2033 ($Billion)
Table 70. UK Immunoassay Market, by Product, 2024 - 2033 ($Billion)
Table 71. UK Immunoassay Market, by Technology, 2024 - 2033 ($Billion)
Table 72. UK Immunoassay Market, by Specimen, 2024 - 2033 ($Billion)
Table 73. UK Immunoassay Market, by End-user, 2024 - 2033 ($Billion)
Table 74. Rest of Europe Immunoassay Market, by Product, 2024 - 2033 ($Billion)
Table 75. Rest of Europe Immunoassay Market, by Technology, 2024 - 2033 ($Billion)
Table 76. Rest of Europe Immunoassay Market, by Specimen, 2024 - 2033 ($Billion)
Table 77. Rest of Europe Immunoassay Market, by End-user, 2024 - 2033 ($Billion)
Table 78. Asia-Pacific Immunoassay Market, by Country, 2024 - 2033 ($Billion)
Table 79. Asia-Pacific Immunoassay Market, by Product, 2024 - 2033 ($Billion)
Table 80. Asia-Pacific Immunoassay Market, by Technology, 2024 - 2033 ($Billion)
Table 81. Asia-Pacific Immunoassay Market, by Specimen, 2024 - 2033 ($Billion)
Table 82. Asia-Pacific Immunoassay Market, by End-user, 2024 - 2033 ($Billion)
Table 83. China Immunoassay Market, by Product, 2024 - 2033 ($Billion)
Table 84. China Immunoassay Market, by Technology, 2024 - 2033 ($Billion)
Table 85. China Immunoassay Market, by Specimen, 2024 - 2033 ($Billion)
Table 86. China Immunoassay Market, by End-user, 2024 - 2033 ($Billion)
Table 87. Japan Immunoassay Market, by Product, 2024 - 2033 ($Billion)
Table 88. Japan Immunoassay Market, by Technology, 2024 - 2033 ($Billion)
Table 89. Japan Immunoassay Market, by Specimen, 2024 - 2033 ($Billion)
Table 90. Japan Immunoassay Market, by End-user, 2024 - 2033 ($Billion)
Table 91. India Immunoassay Market, by Product, 2024 - 2033 ($Billion)
Table 92. India Immunoassay Market, by Technology, 2024 - 2033 ($Billion)
Table 93. India Immunoassay Market, by Specimen, 2024 - 2033 ($Billion)
Table 94. India Immunoassay Market, by End-user, 2024 - 2033 ($Billion)
Table 95. South Korea Immunoassay Market, by Product, 2024 - 2033 ($Billion)
Table 96. South Korea Immunoassay Market, by Technology, 2024 - 2033 ($Billion)
Table 97. South Korea Immunoassay Market, by Specimen, 2024 - 2033 ($Billion)
Table 98. South Korea Immunoassay Market, by End-user, 2024 - 2033 ($Billion)
Table 99. Australia Immunoassay Market, by Product, 2024 - 2033 ($Billion)
Table 100. Australia Immunoassay Market, by Technology, 2024 - 2033 ($Billion)
Table 101. Australia Immunoassay Market, by Specimen, 2024 - 2033 ($Billion)
Table 102. Australia Immunoassay Market, by End-user, 2024 - 2033 ($Billion)
Table 103. Rest of Asia-Pacific Immunoassay Market, by Product, 2024 - 2033 ($Billion)
Table 104. Rest of Asia-Pacific Immunoassay Market, by Technology, 2024 - 2033 ($Billion)
Table 105. Rest of Asia-Pacific Immunoassay Market, by Specimen, 2024 - 2033 ($Billion)
Table 106. Rest of Asia-Pacific Immunoassay Market, by End-user, 2024 - 2033 ($Billion)
Table 107. LAMEA Immunoassay Market, by Country, 2024 - 2033 ($Billion)
Table 108. LAMEA Immunoassay Market, by Product, 2024 - 2033 ($Billion)
Table 109. LAMEA Immunoassay Market, by Technology, 2024 - 2033 ($Billion)
Table 110. LAMEA Immunoassay Market, by Specimen, 2024 - 2033 ($Billion)
Table 111. LAMEA Immunoassay Market, by End-user, 2024 - 2033 ($Billion)
Table 112. Brazil Immunoassay Market, by Product, 2024 - 2033 ($Billion)
Table 113. Brazil Immunoassay Market, by Technology, 2024 - 2033 ($Billion)
Table 114. Brazil Immunoassay Market, by Specimen, 2024 - 2033 ($Billion)
Table 115. Brazil Immunoassay Market, by End-user, 2024 - 2033 ($Billion)
Table 116. South Africa Immunoassay Market, by Product, 2024 - 2033 ($Billion)
Table 117. South Africa Immunoassay Market, by Technology, 2024 - 2033 ($Billion)
Table 118. South Africa Immunoassay Market, by Specimen, 2024 - 2033 ($Billion)
Table 119. South Africa Immunoassay Market, by End-user, 2024 - 2033 ($Billion)
Table 120. Saudi Arabia Immunoassay Market, by Product, 2024 - 2033 ($Billion)
Table 121. Saudi Arabia Immunoassay Market, by Technology, 2024 - 2033 ($Billion)
Table 122. Saudi Arabia Immunoassay Market, by Specimen, 2024 - 2033 ($Billion)
Table 123. Saudi Arabia Immunoassay Market, by End-user, 2024 - 2033 ($Billion)
Table 124. Rest of LAMEA Immunoassay Market, by Product, 2024 - 2033 ($Billion)
Table 125. Rest of LAMEA Immunoassay Market, by Technology, 2024 - 2033 ($Billion)
Table 126. Rest of LAMEA Immunoassay Market, by Specimen, 2024 - 2033 ($Billion)
Table 127. Rest of LAMEA Immunoassay Market, by End-user, 2024 - 2033 ($Billion)
Table 128. F. Hoffmann-La Roche Ltd.: Key Executives
Table 129. F. Hoffmann-La Roche Ltd.: Company Snapshot
Table 130. F. Hoffmann-La Roche Ltd.: Operating Segments
Table 131. F. Hoffmann-La Roche Ltd.: Product Portfolio
Table 132. F. Hoffmann-La Roche Ltd.: Key Strategic Moves and Developments
Table 133. Danaher Corporation: Key Executives
Table 134. Danaher Corporation: Company Snapshot
Table 135. Danaher Corporation: Operating Segments
Table 136. Danaher Corporation: Product Portfolio
Table 137. Danaher Corporation: Key Strategic Moves and Developments
Table 138. Abbott Laboratories: Key Executives
Table 139. Abbott Laboratories: Company Snapshot
Table 140. Abbott Laboratories: Operating Segments
Table 141. Abbott Laboratories: Product Portfolio
Table 142. Abbott Laboratories: Key Strategic Moves and Developments
Table 143. Siemens Healthineers: Key Executives
Table 144. Siemens Healthineers: Company Snapshot
Table 145. Siemens Healthineers: Operating Segments
Table 146. Siemens Healthineers: Product Portfolio
Table 147. Siemens Healthineers: Key Strategic Moves and Developments
Table 148. Diasorin S.P.A.: Key Executives
Table 149. Diasorin S.P.A.: Company Snapshot
Table 150. Diasorin S.P.A.: Operating Segments
Table 151. Diasorin S.P.A.: Product Portfolio
Table 152. Diasorin S.P.A.: Key Strategic Moves and Developments
Table 153. Sysmex Corporation: Key Executives
Table 154. Sysmex Corporation: Company Snapshot
Table 155. Sysmex Corporation: Operating Segments
Table 156. Sysmex Corporation: Product Portfolio
Table 157. Sysmex Corporation: Key Strategic Moves and Developments
Table 158. Biomerieux SA: Key Executives
Table 159. Biomerieux SA: Company Snapshot
Table 160. Biomerieux SA: Operating Segments
Table 161. Biomerieux SA: Product Portfolio
Table 162. Biomerieux SA: Key Strategic Moves and Developments
Table 163. Ortho Clinical Diagnostics: Key Executives
Table 164. Ortho Clinical Diagnostics: Company Snapshot
Table 165. Ortho Clinical Diagnostics: Operating Segments
Table 166. Ortho Clinical Diagnostics: Product Portfolio
Table 167. Ortho Clinical Diagnostics: Key Strategic Moves and Developments
Table 168. Thermo Fisher Scientific, Inc.: Key Executives
Table 169. Thermo Fisher Scientific, Inc.: Company Snapshot
Table 170. Thermo Fisher Scientific, Inc.: Operating Segments
Table 171. Thermo Fisher Scientific, Inc.: Product Portfolio
Table 172. Thermo Fisher Scientific, Inc.: Key Strategic Moves and Developments
Table 173. Becton, Dickinson and Company: Key Executives
Table 174. Becton, Dickinson and Company: Company Snapshot
Table 175. Becton, Dickinson and Company: Operating Segments
Table 176. Becton, Dickinson and Company: Product Portfolio
Table 177. Becton, Dickinson and Company: Key Strategic Moves and Developments
Table 178. Merck KGaA: Key Executives
Table 179. Merck KGaA: Company Snapshot
Table 180. Merck KGaA: Operating Segments
Table 181. Merck KGaA: Product Portfolio
Table 182. Merck KGaA: Key Strategic Moves and Developments
LIST OF FIGURES
Figure 1. Global Immunoassay Market, 2024 - 2033
Figure 2. Segmentation of Immunoassay Market, 2024 - 2033
Figure 3. Top Investment Pocket in Immunoassay Market
Figure 4. Moderate Bargaining Power of Buyers
Figure 5. Moderate Bargaining Power of Suppliers
Figure 6. Moderate Threat of New Entrants
Figure 7. Low Threat of Substitution
Figure 8. High Competitive Rivalry
Figure 9. Opportunities, Restraints and Drivers: Globalimmunoassay Market
Figure 10. Global Immunoassay Market Segmentation, by Product
Figure 11. Immunoassay Market for Reagents and Kits, by Country, 2024 - 2033 ($Billion)
Figure 12. Immunoassay Market for Analyzers, by Country, 2024 - 2033 ($Billion)
Figure 13. Global Immunoassay Market Segmentation, by Technology
Figure 14. Immunoassay Market for Elisa, by Country, 2024 - 2033 ($Billion)
Figure 15. Immunoassay Market for Chemiluminescence Immunoassay, by Country, 2024 - 2033 ($Billion)
Figure 16. Immunoassay Market for Immunofluorescence Assay, by Country, 2024 - 2033 ($Billion)
Figure 17. Immunoassay Market for Rapid Test, by Country, 2024 - 2033 ($Billion)
Figure 18. Immunoassay Market for Elispot, by Country, 2024 - 2033 ($Billion)
Figure 19. Immunoassay Market for Western Blotting, by Country, 2024 - 2033 ($Billion)
Figure 20. Immunoassay Market for Others, by Country, 2024 - 2033 ($Billion)
Figure 21. Global Immunoassay Market Segmentation, by Specimen
Figure 22. Immunoassay Market for Infectious Diseases, by Country, 2024 - 2033 ($Billion)
Figure 23. Immunoassay Market for Endocrinology, by Country, 2024 - 2033 ($Billion)
Figure 24. Immunoassay Market for Oncology, by Country, 2024 - 2033 ($Billion)
Figure 25. Immunoassay Market for Bone and Mineral Disorders, by Country, 2024 - 2033 ($Billion)
Figure 26. Immunoassay Market for Cardiology, by Country, 2024 - 2033 ($Billion)
Figure 27. Immunoassay Market for Blood Screening, by Country, 2024 - 2033 ($Billion)
Figure 28. Immunoassay Market for Autoimmune Disorders, by Country, 2024 - 2033 ($Billion)
Figure 29. Immunoassay Market for Allergy Diagnostics, by Country, 2024 - 2033 ($Billion)
Figure 30. Immunoassay Market for Toxicology, by Country, 2024 - 2033 ($Billion)
Figure 31. Immunoassay Market for Newborn Screening, by Country, 2024 - 2033 ($Billion)
Figure 32. Immunoassay Market for Others, by Country, 2024 - 2033 ($Billion)
Figure 33. Global Immunoassay Market Segmentation, by End-user
Figure 34. Immunoassay Market for Hospitals and Clinics, by Country, 2024 - 2033 ($Billion)
Figure 35. Immunoassay Market for Clinical Laboratories, by Country, 2024 - 2033 ($Billion)
Figure 36. Immunoassay Market for Pharmaceutical and Biotechnology Companies, by Country, 2024 - 2033 ($Billion)
Figure 37. Immunoassay Market for Blood Banks, by Country, 2024 - 2033 ($Billion)
Figure 38. Immunoassay Market for Research and Academic Laboratories, by Country, 2024 - 2033 ($Billion)
Figure 39. Immunoassay Market for Home Care Settings, by Country, 2024 - 2033 ($Billion)
Figure 40. Top Winning Strategies, by Year, 2021-2023*
Figure 41. Top Winning Strategies, by Development, 2021-2023*
Figure 42. Top Winning Strategies, by Company, 2021-2023*
Figure 43. Product Mapping of Top 10 Players
Figure 44. Competitive Dashboard
Figure 45. Competitive Heatmap: Immunoassay Market
Figure 46. Top Player Positioning, 2023
Figure 47. F. Hoffmann-La Roche Ltd.: Net Sales, 2021-2023 ($Billion)
Figure 48. F. Hoffmann-La Roche Ltd.: Revenue Share, by Segment, 2023 (%)
Figure 49. F. Hoffmann-La Roche Ltd.: Revenue Share, by Region, 2023 (%)
Figure 50. Danaher Corporation: Net Sales, 2021-2023 ($Billion)
Figure 51. Danaher Corporation: Revenue Share, by Segment, 2023 (%)
Figure 52. Danaher Corporation: Revenue Share, by Region, 2023 (%)
Figure 53. Abbott Laboratories: Net Sales, 2021-2023 ($Billion)
Figure 54. Abbott Laboratories: Revenue Share, by Segment, 2023 (%)
Figure 55. Abbott Laboratories: Revenue Share, by Region, 2023 (%)
Figure 56. Siemens Healthineers: Net Sales, 2021-2023 ($Billion)
Figure 57. Siemens Healthineers: Revenue Share, by Segment, 2023 (%)
Figure 58. Siemens Healthineers: Revenue Share, by Region, 2023 (%)
Figure 59. Diasorin S.P.A.: Net Sales, 2021-2023 ($Billion)
Figure 60. Diasorin S.P.A.: Revenue Share, by Segment, 2023 (%)
Figure 61. Diasorin S.P.A.: Revenue Share, by Region, 2023 (%)
Figure 62. Sysmex Corporation: Net Sales, 2021-2023 ($Billion)
Figure 63. Sysmex Corporation: Revenue Share, by Segment, 2023 (%)
Figure 64. Sysmex Corporation: Revenue Share, by Region, 2023 (%)
Figure 65. Biomerieux SA: Net Sales, 2021-2023 ($Billion)
Figure 66. Biomerieux SA: Revenue Share, by Segment, 2023 (%)
Figure 67. Biomerieux SA: Revenue Share, by Region, 2023 (%)
Figure 68. Ortho Clinical Diagnostics: Net Sales, 2021-2023 ($Billion)
Figure 69. Ortho Clinical Diagnostics: Revenue Share, by Segment, 2023 (%)
Figure 70. Ortho Clinical Diagnostics: Revenue Share, by Region, 2023 (%)
Figure 71. Thermo Fisher Scientific, Inc.: Net Sales, 2021-2023 ($Billion)
Figure 72. Thermo Fisher Scientific, Inc.: Revenue Share, by Segment, 2023 (%)
Figure 73. Thermo Fisher Scientific, Inc.: Revenue Share, by Region, 2023 (%)
Figure 74. Becton, Dickinson and Company: Net Sales, 2021-2023 ($Billion)
Figure 75. Becton, Dickinson and Company: Revenue Share, by Segment, 2023 (%)
Figure 76. Becton, Dickinson and Company: Revenue Share, by Region, 2023 (%)
Figure 77. Merck KGaA: Net Sales, 2021-2023 ($Billion)
Figure 78. Merck KGaA: Revenue Share, by Segment, 2023 (%)
Figure 79. Merck KGaA: Revenue Share, by Region, 2023 (%)
